Equioxx is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 4 US drug patents filed from 2016 to 2020. All patents have expired. Details of Equioxx’s patents and their expiration are given below.
Equioxx Petitions
Details of Equioxx's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Aurora Pharmaceutical, LLC | Approved | 19 May, 2017 | The proposed change is in dosage form and strength. The RLNAD is approved as an oral paste at 8.2 mg/g. The administration dosage will remain the same at 0.045 mg/lb. The proposed change in strength and dosage form is for a solution at 0.45% w/v. |
About Equioxx
Equioxx is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Equioxx uses
Firocoxib as the active
ingredient.
Active Ingredient:
Equioxx uses
Firocoxib as the active ingredient.
Check out other Drugs and Companies using
Firocoxib ingredient.